跳至主要内容
临床试验/JPRN-UMIN000054009
JPRN-UMIN000054009尚未招募Unknown

Investigation on the anti-obesity effects of research food intake - Investigation on the anti-obesity effects of research food intake

Metagen, Inc.0 个研究点目标入组 20 人开始时间: 2024年3月29日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
Metagen, Inc.
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Subjects who are unable to discontinue consumption of foods for specified health uses, foods with function claims, health foods (including supplements) that may affect the research (anti-obesity, lipid metabolism, appetite control, intestinal regulation, etc.) from the time consent is obtained. (2) Subjects who have taken drugs (antibiotics, antiflatulent, laxatives, etc.) that would affect the study one month prior to the pre-test. (3) Subjects who plan to take drugs that will affect the research during the study. (4) Subjects with a history of appendectomy. (5) Subjects who have undergone surgery that may affect the study (colonoscopy, removal of gallstones or gall bladder, gastric bypass surgery, bariatric surgery, etc.) within 6 months prior to obtaining consent. (6) Subjects undergoing dietary restriction or weight loss. (7) Subjects who plan to lose weight during the study. (8) Subjects who are expected to undergo a major change in their family, work, or other living environment (e.g., relocation, transfer, etc.) during the study. (9) Subjects with extremely irregular eating habits. (10) Subjects with special dietary habits (vegetarian, vegan, low-carbo). (11) Subjects whose roommates plan to participate in the study. (12) Smokers. (13) Heavy alcohol drinkers. (14) Subjects with previously diagnosed diabetes mellitus (type 1/type 2) or dyslipidemia. (15) Subjects with a history of serious diseases of the heart, liver, kidneys, digestive organs, etc. (16) Pregnant, lactating, or intending to become pregnant during the study. (17) Subjects allergic to medicines and foods. (18) Subjects who are aware of excessive abdominal symptoms (severe diarrhea or bloating) when ingesting oligosaccharides. (Due to character limitation, the following will be listed in the "Others" section)

研究者

发起方
Metagen, Inc.

相似试验